Mechanism of Cyclosporine-induced Hypertension

Overview

Journal Am J Hypertens

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 1991 May 1

PMID 2069781

Citations 14

Authors

R G Luke

Affiliations

Soon will be listed here.

Abstract

Cyclosporine is a common immunosuppressive agent used in solid organ and bone marrow transplants and the treatment of some immunological diseases. It has been established that treatment with cyclosporine can cause a patient to develop hypertension within a few weeks of treatment. This review will examine this effect and effective ways to treat it.

Citing Articles

Unlocking Transplant Tolerance with Biomaterials.

Pham J, Coronel M Adv Healthc Mater. 2024; 14(5):e2400965.

PMID: 38843866 PMC: 11834385. DOI: 10.1002/adhm.202400965.

Risk of Developing Hypertension in Atopic Dermatitis Patients Receiving Long-term and Low-dose Cyclosporine: A Nationwide Population-based Cohort Study.

Woo Y, Choi A, Song S, Kim S, Son S, Cho S Ann Dermatol. 2024; 36(2):112-119.

PMID: 38576249 PMC: 10995617. DOI: 10.5021/ad.23.099.

Calcineurin Is a Universal Regulator of Vessel Function-Focus on Vascular Smooth Muscle Cells.

Nolze A, Matern S, Grossmann C Cells. 2023; 12(18).

PMID: 37759492 PMC: 10528183. DOI: 10.3390/cells12182269.

Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?.

Devaux C, Melenotte C, Piercecchi-Marti M, Delteil C, Raoult D Front Med (Lausanne). 2021; 8:663708.

PMID: 34552938 PMC: 8450353. DOI: 10.3389/fmed.2021.663708.

Role of hypertension in kidney transplant recipients.

Loutradis C, Sarafidis P, Marinaki S, Berry M, Borrows R, Sharif A J Hum Hypertens. 2021; 35(11):958-969.

PMID: 33947943 DOI: 10.1038/s41371-021-00540-5.